YoonHwa An/LinkedIn
Sep 14, 2026, 20:53
YoonHwa An: Rusfertide in Polycythemia Vera – From Clinical Benefit to Strategic Value
YoonHwa An, Founder and Principal Strategist, External Strategic Red Team at Biopharma Business Intelligence Unit, shared a post on LinkedIn:
“Rusfertide in Polycythemia Vera: From Clinical Benefit to Strategic Value
Rusfertide’s FDA approval creates a new option for controlling erythrocytosis in polycythemia vera. For clinicians, payers and investors, the next question is how that benefit translates into treatment decisions and sustainable value.
BBIU’s latest Strategic Report examines the connections:
- Clinical evidence: What VERIFY’s response endpoint establishes—and the remaining uncertainty around thrombosis, disease progression and long-term outcomes.
- Health economics: Why avoided phlebotomies alone are unlikely to offset acquisition costs at the reported list price.
- Market access: How coverage, treatment burden and emerging competitors could influence adoption.
- Corporate governance: How Protagonist’s agreement with Takeda shifts commercial exposure, and what investors should examine in royalty economics, executive incentives and capital allocation.
The report connects the clinical findings to the decisions facing biopharma executives, investors and healthcare stakeholders.
Available in BBIU’s Strategic Reports. Access currently requires a free account.”
Stay updated with Hemostasis Today.
-
Sep 14, 2026, 20:52Andres Alberto Mercado Pompa: External Validation of Prognostic Risk Scores in Cerebral Venous Thrombosis
-
Sep 14, 2026, 20:50Balaji Kirushnan: Advancing Regional Citrate Anticoagulation in CRRT – From Experience to Implementation
-
Sep 14, 2026, 20:48Valerie Dehondt: Nutritional Anemia Is Associated With Increased Risk of Severe COPD Exacerbations
-
Sep 14, 2026, 20:46Nupur Choudhury: Exploring AI-Based Detection of Anemia Using Eye and Fingernail Images
-
Sep 14, 2026, 20:44Shamee Shastry: Chart Before You Chase – Diagnosing Drug-Induced Hemolytic Anemia
-
Sep 14, 2026, 20:43David Reiner: Blood Tests That Can Reveal Nutrition Clues
-
Sep 14, 2026, 20:40Giuseppe Biondi Zoccai: Balancing Thrombosis and Bleeding in Acute MI With Hemophilia A
-
Sep 14, 2026, 20:39Kemal Karaagac: Kounis Syndrome as a Possible Cause of Very Late Stent Thrombosis
-
Sep 14, 2026, 20:38Mirvat Alasnag: IVUS and OCT Guided PCI Reduce MACE, Revascularization and Stent Thrombosis